Respiratory Syncytial Virus Infection in Immunocompromised Adults

Abstract

Respiratory syncytial virus disease was documented in 11 immunocompromised adults, aged 21 to 50. Underlying conditions included bone marrow transplant (6 patients), renal transplant (3 patients), renal and pancreas transplants (1 patient), and T-cell lymphoma (1 patient). Diagnosis of infection was based on specimens from bronchoalveolar lavage, sputum, throat, sinus aspirate, and lung biopsy. The virus was detected simultaneously by antibody in either an immunofluorescence or enzyme-linked immunosorbent assay in 3 of 4 patients whose culture results were positive for respiratory syncytial virus. The virus was an unexpected finding, despite widespread infection in the community. Clinical symptoms included low-grade fever, nonproductive cough, rhinorrhea or nasal congestion, and radiographic evidence of interstitial infiltrates and sinusitis. Aerosolized ribavirin therapy was used in the 6 recipients of bone marrow transplants, 3 of whom required assisted ventilation but died. Death caused by virus infection was documented in 4 of 11 patients. Respiratory syncytial virus disease must be considered in the differential diagnosis of fever and pulmonary infiltrates in immunocompromised adults.

Article and Author Information

  • From the University of Minnesota Health Sciences Center, Minneapolis, Minnesota. For current author addresses, see end of text.

  • Requests for Reprints: Henry H. Balfour, Jr., MD, Box 437 UMHC, University of Minnesota, Minneapolis, MN 55455.

  • Current Author Addresses: Drs. Englund and Balfour: Department of Pediatrics, University of Minnesota Hospital, Minneapolis, MN 55455. Drs. Sullivan, Jordan, and Vercellotti: Department of Medicine, University of Minnesota Hospital, Minneapolis, MN 55455.

    Drs. Balfour and Dehner: Department of Laboratory Medicine and Pathology, University of Minnesota Hospital, Minneapolis, MN 55455.

« Previous | Next Article »Table of Contents